中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
24期
66-67,85
,共3页
郑晓华%吴璐皙%朱景威%林子川%马河洲
鄭曉華%吳璐皙%硃景威%林子川%馬河洲
정효화%오로석%주경위%림자천%마하주
曲美他嗪%稳定性心绞痛%运动耐量
麯美他嗪%穩定性心絞痛%運動耐量
곡미타진%은정성심교통%운동내량
Trimetazidine%Stable angina cordis%Exercise tolerance
目的:探讨曲美他嗪对稳定型心绞痛患者疗效及对运动耐量的影响。方法回顾性分析我院2011~2013年心内科收治的300例稳定性心绞痛患者的资料,按照患者治疗方式分为观察组及对照组,各150例,两组患者均给予β受体阻滞剂、阿司匹林、氯吡格雷、钙通道拮抗剂、他汀类常规药物治疗,观察组加用曲美他嗪片,连续治疗2周,对患者进行运动耐量测定,对两组患者治疗后临床症状及运动耐量进行评价。结果观察组患者临床总有效率高,与对照组患者比较差异有统计学意义(P<0.05);观察组患者运动耐量观察指标改善明显,与对照组患者比较差异有统计学意义(P<0.05)。结论曲美他嗪能改善心绞痛患者心肌能量代谢,减少患者心绞痛发作,提高运动耐量,效果满意。
目的:探討麯美他嗪對穩定型心絞痛患者療效及對運動耐量的影響。方法迴顧性分析我院2011~2013年心內科收治的300例穩定性心絞痛患者的資料,按照患者治療方式分為觀察組及對照組,各150例,兩組患者均給予β受體阻滯劑、阿司匹林、氯吡格雷、鈣通道拮抗劑、他汀類常規藥物治療,觀察組加用麯美他嗪片,連續治療2週,對患者進行運動耐量測定,對兩組患者治療後臨床癥狀及運動耐量進行評價。結果觀察組患者臨床總有效率高,與對照組患者比較差異有統計學意義(P<0.05);觀察組患者運動耐量觀察指標改善明顯,與對照組患者比較差異有統計學意義(P<0.05)。結論麯美他嗪能改善心絞痛患者心肌能量代謝,減少患者心絞痛髮作,提高運動耐量,效果滿意。
목적:탐토곡미타진대은정형심교통환자료효급대운동내량적영향。방법회고성분석아원2011~2013년심내과수치적300례은정성심교통환자적자료,안조환자치료방식분위관찰조급대조조,각150례,량조환자균급여β수체조체제、아사필림、록필격뢰、개통도길항제、타정류상규약물치료,관찰조가용곡미타진편,련속치료2주,대환자진행운동내량측정,대량조환자치료후림상증상급운동내량진행평개。결과관찰조환자림상총유효솔고,여대조조환자비교차이유통계학의의(P<0.05);관찰조환자운동내량관찰지표개선명현,여대조조환자비교차이유통계학의의(P<0.05)。결론곡미타진능개선심교통환자심기능량대사,감소환자심교통발작,제고운동내량,효과만의。
Objective To investigate the effect of trimetazidine on curative effect and exercise tolerance in patients with stable angina cordis. Methods The information of 300 patients with stable angina cordis from 2011 to 2013 in the cardiology department of our hospital were retrospectively analyzed. All patients were divided into the observation group and the control group according to the different treatment methods, and each group had 150 cases. The patients of the two groups were both given the conventional drugs treatment, such as beta-blockers, aspirin, clopidogrel, calcium channel blockers, statins, while the patients of the observation group were added with trimetazidine treatment for 2 weeks, and the exercise tolerance of patients were measured. The clinical symptoms and exercise tolerance of patients in the two groups were evaluated after the treatment. Results The clinical total effective rate of the observation group was higher than that of the control group, the difference was statistically significant(P<0.05).The exercise tolerance of the observation group improved more significantly compared with the control group, the difference was statistically significant(P < 0.05). Conclusion Trimetazidine can improve the myocardial energy metabolism in patients with angina cordis, reduce the onset of angina cordis, improve the exercise tolerance, and has satisfactory effect.